{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:45:09Z","timestamp":1757627109658,"version":"3.44.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The potential involvement of <jats:italic>JC polyomavirus<\/jats:italic> (<jats:italic>JCPyV<\/jats:italic>) in prostate cancer (PCa) remains a subject of debate, as existing in vitro studies have produced conflicting results. Understanding the viral oncogenic mechanisms underlying prostate cancer could offer valuable insights into its etiology. This study aimed to explore the association between <jats:italic>JCPyV<\/jats:italic> infection and prostate cancer by detecting the viral large T-antigen gene in prostate tissue specimens.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A case\u2013control study was conducted from February 2022 to March 2023, including 100 participants: 50 diagnosed with prostate cancer (cases) and 50 with benign prostatic hyperplasia (BPH) as controls. Formalin-fixed paraffin-embedded (FFPE) prostate tissue samples were collected from all participants. Nested polymerase chain reaction (PCR) was employed to detect <jats:italic>JCPyV<\/jats:italic> large T-antigen DNA using specific primers. Demographic and clinical data were obtained via a structured questionnaire. Statistical analysis was carried out using SPSS version 20, and associations between <jats:italic>JCPyV<\/jats:italic> presence and prostate cancer were analyzed using logistic regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The mean age of the prostate cancer group was 67.5\u2009\u00b1\u200910.9\u00a0years, compared to 70.9\u2009\u00b1\u20098.9\u00a0years in the control group. <jats:italic>JCPyV<\/jats:italic> large T-antigen DNA was detected in 29 out of 50 (58%) prostate cancer cases, compared to 19 out of 50 (38%) controls (<jats:italic>P<\/jats:italic>\u2009=\u20090.045; odds ratio\u2009=\u20091.45; 95% confidence interval: 1.011 to 5.019). Within the prostate cancer group, patients testing positive for the <jats:italic>JCPyV<\/jats:italic> T-antigen had a mean age of 73.3\u2009\u00b1\u20098.7\u00a0years, significantly higher than T-antigen-negative patients, whose mean age was 67.0\u2009\u00b1\u20098.3\u00a0years (<jats:italic>P<\/jats:italic>\u2009=\u20090.029).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The prevalence of <jats:italic>JCPyV<\/jats:italic> large T-antigen gene was significantly higher in prostate cancer patients than in individuals with benign prostatic hyperplasia. These findings suggest that <jats:italic>JCPyV<\/jats:italic> infection may be linked to an increased risk of prostate cancer, reinforcing prior studies that imply a potential oncogenic role for the virus in prostate carcinogenesis. Further investigations are necessary to elucidate the molecular mechanisms driving this association and its potential clinical implications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s43046-025-00313-y","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T10:24:39Z","timestamp":1756722279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nested PCR detection of JC polyomavirus large T-antigen in prostate cancer tissues: a case\u2013control analysis in a Sudanese population"],"prefix":"10.1186","volume":"37","author":[{"given":"Maria Ahmed Mohamed","family":"Higair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babbiker Mohammed Taher","family":"Gorish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana Eltahir","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"issue":"17\u201318","key":"313_CR1","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1101\/gad.315739.118","volume":"32","author":"G Wang","year":"2018","unstructured":"Wang G, Zhao D, Spring DJ, DePinho RA. Genetics and biology of prostate cancer. Genes Dev. 2018;32(17\u201318):1105\u201340. https:\/\/doi.org\/10.1101\/gad.315739.118.","journal-title":"Genes Dev"},{"issue":"17","key":"313_CR2","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022;27(17):5730.","journal-title":"Molecules"},{"issue":"2","key":"313_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63\u201389. https:\/\/doi.org\/10.14740\/wjon1191.","journal-title":"World J. Oncol."},{"issue":"1","key":"313_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10\u201327. https:\/\/doi.org\/10.14740\/wjon1166.","journal-title":"World J Oncol."},{"key":"313_CR5","doi-asserted-by":"publisher","first-page":"107327482211407","DOI":"10.1177\/10732748221140785","volume":"29","author":"BMT Gorish","year":"2022","unstructured":"Gorish BMT. JC Polyoma virus as a possible risk factor for prostate cancer development - immunofluorescence and molecular-based case-control study. Cancer Control. 2022;29:10732748221140784. https:\/\/doi.org\/10.1177\/10732748221140785.","journal-title":"Cancer Control"},{"key":"313_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13027-019-0244-7","volume":"14","author":"BMT Gorish","year":"2019","unstructured":"Gorish BMT, Ournasseir MEH, Shammat IM. A correlation study of BK Polyoma Virus infection and prostate cancer among Sudanese patients - immunofluorescence and molecular-based case-control study. Infectious Agents and Cancer. 2019;14:25. https:\/\/doi.org\/10.1186\/s13027-019-0244-7.","journal-title":"Infectious Agents and Cancer"},{"issue":"10","key":"313_CR7","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3390\/v12101192","volume":"12","author":"S Saribas","year":"2020","unstructured":"Saribas S, Safak M. A comprehensive proteomics analysis of the JC virus (JCV) large and small tumor antigen interacting proteins: large T primarily targets the host protein complexes with v-ATPase and ubiquitin ligase activities while small t mostly associates with those having phosphatase and chromatin-remodeling functions. Viruses. 2020;12(10):1192.","journal-title":"Viruses"},{"issue":"Suppl 1","key":"313_CR8","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.jinf.2013.09.009","volume":"68","author":"M Pinto","year":"2014","unstructured":"Pinto M, Dobson S. BK and JC Virus: A Review. J Infect. 2014;68(Suppl 1):S2\u20138. https:\/\/doi.org\/10.1016\/j.jinf.2013.09.009.","journal-title":"J Infect"},{"issue":"3","key":"313_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1128\/CMR.05031-11","volume":"25","author":"MW Ferenczy","year":"2012","unstructured":"Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, Major EO. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25(3):471\u2013506. https:\/\/doi.org\/10.1128\/CMR.05031-11.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"313_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s13365-019-00753-y","volume":"25","author":"SM Corbridge","year":"2019","unstructured":"Corbridge SM, Rice RC, Bean LA, W\u00fcthrich C, Dang X, Nicholson DA, Koralnik IJ. JC virus infection of meningeal and choroid plexus cells in patients with progressive multifocal leukoencephalopathy. J Neurovirol. 2019;25(4):520\u20134. https:\/\/doi.org\/10.1007\/s13365-019-00753-y.","journal-title":"J Neurovirol"},{"issue":"7","key":"313_CR11","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/infdis\/jiab639","volume":"226","author":"AS L'Honneur","year":"2022","unstructured":"L\u2019Honneur AS, Pipoli Da Fonseca J, Cokelaer T, Rozenberg F. JC Polyomavirus whole genome sequencing at the single-molecule level reveals emerging neurotropic populations in progressive multifocal leukoencephalopathy. J Infect Dis. 2022;226(7):1151\u201361. https:\/\/doi.org\/10.1093\/infdis\/jiab639.","journal-title":"J Infect Dis."},{"key":"313_CR12","doi-asserted-by":"publisher","first-page":"197860","DOI":"10.1016\/j.virusres.2020.197860","volume":"278","author":"I Hussain","year":"2020","unstructured":"Hussain I, Tasneem F, Gilani US, Arshad MI, Farhan Ul Haque M, Abbas Z, Umer M, Shahzad N. Human BK and JC polyomaviruses: molecular insights and prevalence in Asia. Virus Res. 2020;278:197860. https:\/\/doi.org\/10.1016\/j.virusres.2020.197860.","journal-title":"Virus Res."},{"issue":"1","key":"313_CR13","first-page":"3","volume":"1","author":"KS Sfanos","year":"2013","unstructured":"Sfanos KS, Isaacs WB, De Marzo AM. Infections and inflammation in prostate cancer. American Journal of Clinical and Experimental Urology. 2013;1(1):3\u201311.","journal-title":"American Journal of Clinical and Experimental Urology"},{"issue":"1","key":"313_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1186\/s12885-021-08862-w","volume":"21","author":"C Shen","year":"2021","unstructured":"Shen C, Tung C, Chao C, Jou Y, Huang S, Meng M, Chang D, Chen P. The differential presence of human polyomaviruses, JCPyV and BKPyV, in prostate cancer and benign prostate hypertrophy tissues. BMC Cancer. 2021;21(1):1141. https:\/\/doi.org\/10.1186\/s12885-021-08862-w.","journal-title":"BMC Cancer"},{"issue":"4","key":"313_CR15","first-page":"189","volume":"12","author":"E Anzivino","year":"2015","unstructured":"Anzivino E, Rodio DM, Mischitelli M, Bellizzi A, Sciarra A, Salciccia S, Gentile V, Pietropaolo V. High frequency of JCV DNA detection in prostate cancer tissues. Cancer Genomics Proteomics. 2015;12(4):189\u2013200.","journal-title":"Cancer Genomics Proteomics"},{"issue":"1","key":"313_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/sj.bjc.6603480","volume":"96","author":"J Bergh","year":"2007","unstructured":"Bergh J, Marklund I, Gustavsson C, Wiklund F, Gr\u00f6nberg H, Allard A, Alexeyev O, Elgh F. No link between viral findings in the prostate and subsequent cancer development. Br J Cancer. 2007;96(1):137\u20139. https:\/\/doi.org\/10.1038\/sj.bjc.6603480.","journal-title":"Br J Cancer"},{"issue":"8","key":"313_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573\u20137. https:\/\/doi.org\/10.7326\/0003-4819-147-8-200710160-00010.","journal-title":"Ann Intern Med."},{"issue":"3","key":"313_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF02686010","volume":"35","author":"M Bergallo","year":"2007","unstructured":"Bergallo M, Costa C, Margio S, Sidoti F, Segoloni GP, Ponzi AN, Cavallo R. Detection and typing of BKV, JCpyV, and SV40 by multiplex nested polymerase chain reaction. Mol Biotechnol. 2007;35(3):243\u201352. https:\/\/doi.org\/10.1007\/BF02686010.","journal-title":"Mol Biotechnol"},{"doi-asserted-by":"publisher","unstructured":"Hu Y. Regulatory Concern of Polymerase Chain Reaction (PCR) Carryover Contamination. In Polymerase Chain Reaction for Biomedical Applications. InTech. 2016. https:\/\/doi.org\/10.5772\/66294.","key":"313_CR19","DOI":"10.5772\/66294"},{"issue":"3","key":"313_CR20","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.21037\/tau-20-853","volume":"10","author":"R Montironi","year":"2021","unstructured":"Montironi R, Cheng L, Cimadamore A, Mazzucchelli R, Scarpelli M, Santoni M, Massari F, Lopez-Beltran A. Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups? Transl Androl Urol. 2021;10(3):1530\u201340. https:\/\/doi.org\/10.21037\/tau-20-853.","journal-title":"Transl Androl Urol."},{"issue":"4","key":"313_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/pros.10157","volume":"53","author":"A Zambrano","year":"2002","unstructured":"Zambrano A, Kalantari M, Simoneau A, Jensen JL, Villarreal LP. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate. 2002;53(4):263\u201376. https:\/\/doi.org\/10.1002\/pros.10157.","journal-title":"Prostate"},{"key":"313_CR22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/1471-2407-10-326","volume":"10","author":"ML Martinez-Fierro","year":"2010","unstructured":"Martinez-Fierro ML, Leach RJ, Gomez-Guerra LS, Garza-Guajardo R, Johnson-Pais T, Beuten J, Morales-Rodriguez IB, Hernandez-Ordo\u00f1ez MA, Calderon-Cardenas G, Ortiz-Lopez R, et al. Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer. 2010;10:326. https:\/\/doi.org\/10.1186\/1471-2407-10-326.","journal-title":"BMC Cancer"},{"key":"313_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13027-017-0122-0","volume":"12","author":"S Delbue","year":"2017","unstructured":"Delbue S, Comar M, Ferrante P. Review on the role of the human Polyomavirus JC in the development of tumors. Infectious Agents and Cancer. 2017;12:10. https:\/\/doi.org\/10.1186\/s13027-017-0122-0.","journal-title":"Infectious Agents and Cancer"},{"key":"313_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216759","volume":"588","author":"Q Liu","year":"2024","unstructured":"Liu Q, Li S. Exosomal circRNAs: novel biomarkers and therapeutic targets for urinary tumors. Cancer Lett. 2024;588: 216759. https:\/\/doi.org\/10.1016\/j.canlet.2024.216759.","journal-title":"Cancer Lett"},{"issue":"1","key":"313_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12943-024-02095-8","volume":"23","author":"Q Liu","year":"2024","unstructured":"Liu Q, Guan Y, Li S. Programmed death receptor (PD-1)\/PD-ligand (PD-L1) in urological cancers: the \u201call-around warrior\u201d in immunotherapy. Mol Cancer. 2024;23(1):183. https:\/\/doi.org\/10.1186\/s12943-024-02095-8.","journal-title":"Mol Cancer"},{"key":"313_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100937","volume":"67","author":"X Guo","year":"2023","unstructured":"Guo X, Gao C, Yang DH, Li S. Exosomal circular RNAs: a chief culprit in cancer chemotherapy resistance. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 2023;67: 100937. https:\/\/doi.org\/10.1016\/j.drup.2023.100937.","journal-title":"Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy"},{"issue":"1","key":"313_CR27","doi-asserted-by":"publisher","first-page":"189033","DOI":"10.1016\/j.bbcan.2023.189033","volume":"1879","author":"S Li","year":"2024","unstructured":"Li S, Kang Y, Zeng Y. Targeting tumor and bone microenvironment: novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis.\u00a0Biochimica et Biophysica Acta. Reviews on Cancer. 2024;1879(1):189033. https:\/\/doi.org\/10.1016\/j.bbcan.2023.189033.","journal-title":"Reviews on Cancer."},{"issue":"3","key":"313_CR28","first-page":"337","volume":"10","author":"BM Gorish","year":"2019","unstructured":"Gorish BM, Ournasseir ME, Shammat IM. Effect of age, geographical affiliation, and environmental factors on the development of prostate cancer among Sudanese patients. J Carcinog Mutagen. 2019;10(3):337.","journal-title":"J Carcinog Mutagen"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00313-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-025-00313-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00313-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:57:36Z","timestamp":1757465856000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-025-00313-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["313"],"URL":"https:\/\/doi.org\/10.1186\/s43046-025-00313-y","relation":{},"ISSN":["2589-0409"],"issn-type":[{"type":"electronic","value":"2589-0409"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent before participation in the study. The study was conducted following the Declaration of Helsinki. Ethical approval for this study was obtained from Al-Neelain University, which ethically approved the proposal (Approval number NU-23\u201311-2019). All participants provided written informed consent before participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}